In a first-of-its-kind pilot in the US, Nolla Health will use AI to diagnose and prescribe acne medications to Utah patients without direct human oversight (Annika Inampudi/Bloomberg)
In a first-of-its-kind pilot, Nolla Health lets AI diagnose and issue prescriptions. — An AI-based healthcare startup on Monday …
Nolla Health is launching a pilot program in Utah that uses artificial intelligence to diagnose and prescribe acne medications to patients. The AI system will assess patients with mild-to-moderate acne by analyzing a structured intake and photos of their skin.
The AI will determine if a low-risk drug is suitable for treatment. Initially, a licensed clinician will review the AI's decisions and sign off on prescriptions. According to STAT News, Nolla Health raised $4.5 million from investors, including General Catalyst, and aims to use AI to direct treatment for various conditions.
This pilot program is part of Utah's "AI sandbox" initiative, which allows companies to test AI products under state supervision with certain regulations waived. The program marks a first-of-its-kind pilot in the US, where AI is used to diagnose and prescribe medications without direct human oversight.
Brief written by urgent.news from Techmeme, STAT News — 2 reports on this story. Machine-written — may contain errors; check the original before relying on it.
